XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
6 Months Ended
Jan. 31, 2019
Fair Value Measurements [Abstract]  
Fair Value Measurements

Note 9—Fair Value Measurements

 

In the first quarter of fiscal 2019, the Company adopted ASU No. 2018-13, Fair Value Measurement (Topic 820), that modifies the disclosure requirements for fair value measurements. The adoption of this ASU did not impact the fair value measurement disclosures in the Company’s consolidated financial statements for the three and six months ended January 31, 2019, however it may impact the Company’s fair value measurement disclosures in the future.

 

The following tables present the balance of assets measured at fair value on a recurring basis:

 

  Level 1 (1)  Level 2 (2)  Level 3 (3)  Total 
  (in thousands) 
January 31, 2019            
Debt securities $749  $302  $          —  $1,051 
Equity securities included in other current assets  497         497 
Equity securities included in equity investments        2,745   2,745 
Total $1,246  $302  $2,745  $4,293 
                 
July 31, 2018                
Debt securities $1,692  $3,920  $  $5,612 
Equity securities included in other current assets  360         360 
Total $2,052  $3,920  $  $5,972 

 

(1) – quoted prices in active markets for identical assets or liabilities

(2) – observable inputs other than quoted prices in active markets for identical assets and liabilities

(3) – no observable pricing inputs in the market

 

At January 31, 2019 and July 31, 2018, the Company did not have any liabilities measured at fair value on a recurring basis.

 

The following table summarizes the change in the balance of the Company’s assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3). There were no liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) in the three and six months ended January 31, 2019 and 2018.

 

  Three Months Ended
January 31,
  Six Months Ended
January 31,
 
  2019  2018  2019  2018 
  (in thousands) 
Balance, beginning of period $2,816  $6,300  $  $6,300 
Transfer into Level 3 from adoption of change in accounting for equity investments        2,794    
Total losses recognized in “Other income (expense), net”  (71)     (49)   
Balance, end of period $2,745  $6,300  $2,745  $6,300 
                 
Change in unrealized gains or losses for the period included in earnings for assets held at the end of the period $(71) $  $(49) $ 

 

At January 31, 2019 and July 31, 2018, the Company had $4.8 million in investments in hedge funds, which were included in “Equity investments” in the accompanying consolidated balance sheets. The Company’s investments in hedge funds were accounted for using the equity method, therefore they were not measured at fair value.

 

Fair Value of Other Financial Instruments

 

The estimated fair value of the Company’s other financial instruments was determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting these data to develop estimates of fair value. Consequently, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange.

 

Cash and cash equivalents, restricted cash and cash equivalents, other current assets, customer deposits and other current liabilities. At January 31, 2019 and July 31, 2018, the carrying amount of these assets and liabilities approximated fair value because of the short period of time to maturity. The fair value estimates for cash, cash equivalents and restricted cash and cash equivalents were classified as Level 1 and other current assets, customer deposits and other current liabilities were classified as Level 2 of the fair value hierarchy.

 

Other assets and other liabilities. At January 31, 2019 and July 31, 2018, the carrying amount of these assets and liabilities approximated fair value. The fair values were estimated based on the Company’s assumptions, which were classified as Level 3 of the fair value hierarchy.